N
Nicole Eter
Ophthalmologist
3
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
Aug 12, 2026
Episode 86: The Dark Side of the Moon: Prof Frank Holz on Dry AMD and a Career in Retina
1:45
1:52
2:03
7:20

Nicole EterGUEST
And well, today I have the great pleasure of speaking with Professor Frank Holtz.

Nicole EterGUEST
He's past president of Uretina, as you already mentioned, and the leading figure in retinal research and particularly in age-related macular degeneration.

Nicole EterGUEST
Frank, you are a professor and chairman of the Department of Ophthalmology at the University of Bonn.
5 MINS LATER

Frank HolzGUEST
in this relatively slow progressing disease to pick out those who are a bit faster and you come up with reasonable results as we learn then later with complementary inhibitors and other therapeutic agents that you can have a meaningful result and look already at 12 or 24 months.
Episode 84: Inside Euretina Innovation Spotlight: Retina, Industry & Regulators
1:35
1:44
1:54
2:03
2:24
4:04

Jonathan McRaeHOST
Nicole, you might first start off by explaining what exactly EIS is and why this is a separate event from Uretina.

Nicole EterGUEST
I think EIS was born out of the recognition that innovation in ophthalmology is moving faster than ever before.

Nicole EterGUEST
And we needed a place where everyone can be involved in that journey and can come together.

Nicole EterGUEST
And of course, scientific meetings like Euretina are fantastic for presenting new clinical data, but innovation is about much more than science alone.

Nicole EterGUEST
And those conversations, if they don't happen, great ideas are not developing and they will never reach our patients.

Jonathan McRaeHOST
Nicole, how significant is it that Jane Mosley from the European Medicines Agency is returning? Because to have her as a speaker last year was wonderful, but it really says something that she's come back because this is obviously something that the EMA sees as an important event.
Episode 81: The Women in Retina survey - 5 years on
15:34
15:43
15:50
16:03
16:19
16:50

Jonathan McRaeHOST
Why is it important to involve everybody in this survey, not just the women researchers, women clinicians, women retina specialists?

Nicole EterGUEST
Yeah, well, because improving opportunity and representation is not a woman's issue.

Nicole EterGUEST
And the retina field benefits when the best ideas, perspectives and talents are fully represented.

Nicole EterGUEST
We need all the men to support this and meaningful change requires participation from everyone, especially because leadership positions, mentorship networks and decision making structures involve both women and men.

Nicole EterGUEST
And men are colleagues, mentors, sponsors, department heads and leaders who can help create an environment where talent is recognized and supported.

Jonathan McRaeHOST
When you look back on this time, on this survey, what do you hope to be able to say this work achieved?